A CURE FOR CHRONIC HEPATITIS B (HBV)

Hepatitis B Virus (HBV) is the second most common cause of cancer worldwide. Over 2 billion (1 out of every 3) people in the world have had an acute infection of HBV. Over 300 million are chronic HBV carriers, at risk for liver cancer and liver failure. However, today, no cure for Hepatitis B exists. A novel, curative medicine for HBV would not only save hundreds of millions of lives, but also resolve a massive public health crisis, with significant social and economic benefits.

​

Our therapeutic is a one-time cure for HBV containing CRISPR-Cas9s that recognize the DNA sequence for two HBV-related targets in order to ultimately eliminate the virus from infected liver cells.